Jason C. Jones's most recent trade in Ekso Bionics Holdings Inc was a trade of 24,248 Common Stock done . Disclosure was reported to the exchange on March 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 24,248 | 47,113 (0%) | 0% | - | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2024 | 7,474 | 22,865 (0%) | 0% | - | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 08 May 2023 | 3,435 | 138,554 (0%) | 0% | 1.6 | 5,401 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Senior VP Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2022 | 17,007 | 141,989 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Senior VP Product Development | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 16 Nov 2022 | 782 | 124,982 (0%) | 0% | 1.3 | 1,003 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | Senior VP Product Development | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 31 Aug 2022 | 5,873 | 125,764 (0%) | 0% | 2.3 | 13,587 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 50,000 | 131,637 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 22 Mar 2022 | 3,265 | 81,637 (0%) | 0% | 2.8 | 9,206 | Common Stock |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 13,760 | 84,902 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 10,800 | 15,391 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,446 | 4,591 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | VP of Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 12,270 | 21,142 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 170,454 | 329,008 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 20,000 | 158,554 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 10,800 | 15,291 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 3,346 | 4,491 (0%) | 0% | 0 | Common Stock | |
| Ekso Bionics Holdings Inc | Jason C. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 1,145 | 1,145 (0%) | 0% | 0 | Common Stock |